ARCHIVES

CTI Files Appeal Over FDA’s Decision on Pixantrone

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Raymond Weiss Reviews Confidential Report on I-ELCAP

April 29, 2011

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995

Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center.

July 21, 2000

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014